South African Biotech Startup Immobazyme Secures $1.3 Million to Scale Biotech Operations

South African Biotech Startup Immobazyme Secures $1.3 Million to Scale Biotech Operations

Immobazyme, a South African biotech startup founded in 2019, has secured a significant funding boost of $1.3 million. This exciting development marks a major step forward for the company, allowing them to scale up their operations and introduce their innovative solutions to the global market.

Pioneering Precision Fermentation for a Sustainable Future

Immobazyme’s cutting-edge technology lies in precision fermentation. This unique process combines traditional fermentation techniques with genetic engineering to produce high-value, active protein ingredients.

Imagine a world where essential products are created without relying on traditional methods,that’s the power Immobazyme holds.

READ ALSO:

Egyptian Healthtech Startup i’SUPPLY Secures Funding to Scale Operations

Diverse Applications Across Industries

Immobazyme’s product portfolio is a testament to the versatility of precision fermentation. They offer a range of solutions that cater to various industries, including:

  • Food and Beverage: Immobazyme manufactures essential ingredients like growth factors, crucial for the burgeoning cell-cultured meat industry.
  • Sugar Production: Their enzymes, like dextranase, tackle common contaminants in sugar, improving efficiency and yield.
  • Biopharmaceuticals: Immobazyme’s technology has the potential to change the production of vital drugs and vaccines.

Investment Fuels Growth and Global Impact

The funding round was led by the University Technology Fund (UTF) and University of Stellenbosch Enterprises. Investors expressed confidence in Immobazyme’s potential, highlighting their unique enzyme immobilisation platform.

This technology enhances the stability and efficiency of enzymes, making them even more valuable for industrial applications.

Dominic Nicholas, CEO of Immobazyme, sees the funding as a springboard for tackling real-world challenges. “We are committed to delivering economic, social, and environmental benefits through our technology,” he stated. The immediate focus will be on expanding their facility to meet global demand.

A Beacon of Innovation: Stellenbosch University Connection

The investment in Immobazyme is a prime example of how local university-developed technologies can become powerful assets. Anita Nel, from Stellenbosch University, emphasised this point, showcasing the university’s commitment to encouraging innovation and entrepreneurship.

READ ALSO:

RMB Backs Africa Data Centres’ $108.9 Million Growth Strategy

Immobazyme’s Products

  • Enzymes: Immobazyme’s PepTrap platform transforms enzyme use. It integrates these biocatalysts seamlessly into various industrial settings, improving their stability and efficiency. This technology can be adapted for small-scale labs or large-scale industrial pipelines.
  • Dextranase: This enzyme is a game-changer for sugar production. It efficiently breaks down dextran contaminants, a major hurdle in the sugar industry, leading to increased yield and higher quality sugar.
  • Growth Factors: Immobazyme’s modular protein expression system allows for the cost-effective production of high-quality growth factors. These factors have applications in regenerative medicine, stem cell research, tissue engineering, and even the development of cosmeceutical products.

With this funding and their commitment to innovation, Immobazyme is positioned to become a leader in the biotechnology industry. Their focus on precision fermentation offers a glimpse into a more sustainable future, where essential products are created with minimal environmental impact.

From tastier cell-cultured meat to a more efficient sugar industry, Immobazyme’s solutions have the potential to transform various sectors and create a positive global impact.

Leave a Reply

Your email address will not be published. Required fields are marked *